Fortress Biotech, Inc. (FBIO) Net margin 2016–2025
Fortress Biotech, Inc. (FBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
58.5%FY2025 · since FY2016: -334.3% → 58.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 58.5% | +22.1 pp |
| FY2024 | 36.4% | -0.3 pp |
| FY2023 | 36.7% | +151.0 pp |
| FY2022 | -114.3% | -20.2 pp |
| FY2021 | -94.1% | +8.0 pp |
| FY2020 | -102.0% | +7.1 pp |
| FY2019 | -109.1% | +203.9 pp |
| FY2018 | -313.0% | +74.8 pp |
| FY2017 | -387.8% | -53.5 pp |
| FY2016 | -334.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice